Cefadroxil, MP Biomedicals™

Specifications

Chemical Identifiers

• CAS: 50370-12-2
• Molecular Formula: C16H17N3O5S
• Molecular Weight (g/mol): 363.388
• MDL Number: MFCD00865091
• InChI Key: BOEGTKLJZSQCCD-UEKVPHQBSA-N
• Synonym: p-hydroxycephalexine, Cefamox
• PubChem CID: 47965
• ChEBI: CHEBI:3479
• IUPAC Name: (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• SMILES: CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O

• Type: Cefadroxil
• Physical Form: Crystalline Powder
• Formula Weight: 363.4
• Color: White
• Quantity: 5 g
• Chemical Name or Material: Cefadroxil

Safety and Handling

Product Identifier

• Cefadroxil

Signal Word

• Danger

Hazard Category

• Serious eye damage/eye irritation Category 2
• Respiratory sensitiser Category 1
• Skin corrosion/irritation Category 2
• Skin sensitiser Category 1
• Specific target organ toxicity Category 3

Hazard Statement

• H315-Causes skin irritation.
• H317-May cause an allergic skin reaction.
• H319-Causes serious eye irritation.
• H334-May cause allergy or asthma symptoms or breathing difficulties if inhaled.
• H335-May cause respiratory irritation.

Precautionary Statement

• P261-Avoid breathing dust/fume/gas/mist/vapours/spray.
• P284-¢In case of inadequate ventilation! wear respiratory protection.
• P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
• P321-Specific treatment (see on this label).
• P405-Store locked up.
• P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.

Supplemental information

• MIXTURE LIST-Contains : Cefadroxil